|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||78.94 - 78.94|
|52 Week Range||38.72 - 81.25|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The Zacks Analyst Blog Highlights: ResMed, Ensign, DaVita, KalVista Pharmaceuticals and MEI Pharma
DaVita HealthCare (DVA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The company continues to focus on state policy, but will not pursue its own ballot initiative in California.
DaVita HealthCare (DVA) delivered earnings and revenue surprises of 12.05% and -0.61%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
DaVita (NYSE: DVA ) reported quarterly earnings of $1.86 per share on Monday, which beat the analyst consensus estimate of $1.66. This is a 106% increase over earnings of 90 cents per share from the same ...
On Monday, February 10, DaVita (NYSE: DVA ) will release its latest earnings report. Check out Benzinga's preview to understand the implications. Earnings and Revenue Analysts covering DaVita modeled for ...
Today we're going to take a look at the well-established DaVita Inc. (NYSE:DVA). The company's stock saw a significant...
Davita Inc (NYSE: DVA ) surged to all-time highs Friday after winning the praise of a new market advocate. Medicare is largely to thank. The Rating Goldman Sachs analysts led by Stephen Tanal upgraded ...
Warren Buffett, chairman and CEO of legendary holding company Berkshire Hathaway (BRK.B), is often called the greatest value investor of all time. Although Buffett identifies targets based on their "intrinsic value," a number of Berkshire's holdings look like cheap stocks by more prosaic value indicators, too.Not every stock held by Berkshire Hathaway is necessarily a bargain at its current share price. After all, Buffett has held some of these names for decades. To that end, we scoured Berkshire Hathaway's portfolio of nearly 50 stocks to find the ones that look like they're on sale these days.In some cases, we relied on forward price-to-earnings multiples, which show what a stock costs in light of its expected earnings growth. (The S&P; 500, by the way, trades at 18.6 times expected earnings, by Yardeni Research's calculations.) In others, we also took into consideration book values. And naturally we paid attention to long-term growth forecasts and fundamentals.After sorting through the Berkshire Hathaway equity portfolio with those criteria in mind, these 10 names stood out among the cheapest Warren Buffett stocks. SEE ALSO: Every Warren Buffett Stock Ranked: The Berkshire Hathaway Portfolio
A new kidney-care organization founded by former DaVita executives is looking to use predictive analytics to catch kidney disease in patients earlier. Strive Health, launched in Denver in 2018, has now secured a key partnership with SSM Health, a health system. Strive is the brainchild of former DaVita Inc. (NYSE: DVA) executives Bob Badal and Chris Riopelle.
Hedge funds are known to underperform the bull markets but that's not because they are bad at investing. Truth be told, most hedge fund managers and other smaller players within this industry are very smart and skilled investors. Of course, they may also make wrong bets in some instances, but no one knows what the […]